Breaking News Instant updates and real-time market news.

VNE

Veoneer

$16.59

-0.18 (-1.07%)

06:24
10/23/19
10/23
06:24
10/23/19
06:24

Veoneer sees FY19 revenue down in low double digits

  • 23

    Oct

  • 29

    Oct

  • 09

    Dec

VNE Veoneer
$16.59

-0.18 (-1.07%)

06/27/19
FBCO
06/27/19
INITIATION
Target $18
FBCO
Neutral
Veoneer initiated with a Neutral at Credit Suisse
Credit Suisse analyst Dan Levy started coverage of Veoneer with a Neutral rating and $18 price target. The analyst believes it offers a "unique narrative" versus other parts suppliers, and presents the potential to be the "best organic revenue growth story," while also offering the highest relative exposure to the high-growth active safety space. Yet the challenge for the company will be to pivot to profitability, he contended. With significant resources required to execute its growth plan, Levy does not expect Veoneer to reach EBIT breakeven before 2023.
07/17/19
SBSH
07/17/19
DOWNGRADE
Target $144
SBSH
Neutral
Lear downgraded to Neutral from Buy at Citi
Citi analyst Itay Michaeli downgraded Lear (LEA) to Neutral from Buy and lowered his price target on the stock to $144 from $188 following the company's 2019 guidance cut, which he contends "might not be fully explained by macro alone." Given the double-digit percentage cut to Lear's FY19 net income outlook, the reaction in the stock today "appears rather mild," said the analsyt, who added that the guidance cut suggests to him a worsening of some of the E-Systems revenue issues he'd previously called out. On the surface, the news appears to have a negative-read for suppliers with heavy exposure in Europe and China - such as Visteon (VC), Autoliv (ALV), Veoneer (VNE), BorgWarner (BWA) and Aptiv (APTV) - but Michaeli reiterated that he thinks there are also company-specific factors in play.
10/15/19
GUGG
10/15/19
INITIATION
GUGG
Neutral
Veoneer initiated with a Neutral at Guggenheim
Guggenheim analyst Ali Faghri started Veoneer with a Neutral rating.
10/16/19
GUGG
10/16/19
INITIATION
GUGG
Guggenheim initiates Auto Suppliers with cautious sector view
Guggenheim analyst Ali Faghri initiated coverage last night on the Auto Suppliers with a cautious sector view. The automotive sector is facing increasing cyclical pressures globally, says Faghri, who forecasts flat to negative global industry production volumes through 2021. This creates a challenging operating environment for auto suppliers, the analyst tells investors in a research note. Faghri believes Europe represents the most significant risk to the group's outlook, pointing out that his work suggests "macro headwinds and disruptive emissions regulations will significantly impact vehicle demand in the region over the next few years." The analyst initiated coverage of Aptiv (APTV) and Gentex (GNTX) with Buy ratings. For Aptiv, he sees high single-digit organic growth through 2022 driven by active safety and electric vehicle content gains. For Gentex, the analyst sees upside to 2019 consensus due to stronger gross margins and visibility for continued above market growth. Faghri rounded out his coverage with Neutral ratings on BorgWarner (BWA), Delphi Technologies (DLPH), Lear (LEA), Visteon (VC) and Veoneer (VNE).

TODAY'S FREE FLY STORIES

XLK

Technology Select Sector SPDR

$86.72

-0.4 (-0.46%)

08:23
11/22/19
11/22
08:23
11/22/19
08:23
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$60.00

0.95 (1.61%)

08:23
11/22/19
11/22
08:23
11/22/19
08:23
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$119.56

-0.62 (-0.52%)

08:23
11/22/19
11/22
08:23
11/22/19
08:23
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$59.26

-0.065 (-0.11%)

08:23
11/22/19
11/22
08:23
11/22/19
08:23
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$62.98

-0.23 (-0.36%)

08:22
11/22/19
11/22
08:22
11/22/19
08:22
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$61.36

-0.32 (-0.52%)

08:22
11/22/19
11/22
08:22
11/22/19
08:22
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$97.91

0.24 (0.25%)

08:22
11/22/19
11/22
08:22
11/22/19
08:22
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$14.67

-0.35 (-2.33%)

08:22
11/22/19
11/22
08:22
11/22/19
08:22
Recommendations
Macy's analyst commentary  »

Macy's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$157.73

-0.86 (-0.54%)

08:22
11/22/19
11/22
08:22
11/22/19
08:22
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$277.76

-0.41 (-0.15%)

08:21
11/22/19
11/22
08:21
11/22/19
08:21
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$310.30

-0.5 (-0.16%)

08:21
11/22/19
11/22
08:21
11/22/19
08:21
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$29.69

-0.02 (-0.07%)

08:21
11/22/19
11/22
08:21
11/22/19
08:21
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBS

Emergent BioSolutions

$52.46

-1.9 (-3.50%)

08:20
11/22/19
11/22
08:20
11/22/19
08:20
Hot Stocks
Emergent BioSolutions presents immunogenicity results from Phase 2 study »

Emergent BioSolutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$131.14

-1.45 (-1.09%)

08:20
11/22/19
11/22
08:20
11/22/19
08:20
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$201.67

-0.45 (-0.22%)

08:20
11/22/19
11/22
08:20
11/22/19
08:20
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:20
11/22/19
11/22
08:20
11/22/19
08:20
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDX

Nasdaq 100 Index

$0.00

(0.00%)

08:20
11/22/19
11/22
08:20
11/22/19
08:20
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALB

Albemarle

$65.17

0.12 (0.18%)

, SQM

SQM

$23.29

-0.12 (-0.51%)

08:19
11/22/19
11/22
08:19
11/22/19
08:19
Recommendations
Albemarle, SQM analyst commentary  »

Albemarle price target…

ALB

Albemarle

$65.17

0.12 (0.18%)

SQM

SQM

$23.29

-0.12 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

PSTG

Pure Storage

$19.84

-0.22 (-1.10%)

08:17
11/22/19
11/22
08:17
11/22/19
08:17
Recommendations
Pure Storage analyst commentary  »

Pure Storage price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 09

    Dec

  • 12

    Dec

  • 10

    Mar

  • 11

    Mar

CGC

Canopy Growth

$20.28

2.65 (15.03%)

, ACB

Aurora Cannabis

$3.12

0.48 (18.18%)

08:16
11/22/19
11/22
08:16
11/22/19
08:16
Recommendations
Canopy Growth, Aurora Cannabis analyst commentary  »

Canopy Growth, Aurora…

CGC

Canopy Growth

$20.28

2.65 (15.03%)

ACB

Aurora Cannabis

$3.12

0.48 (18.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMPY

Amplify Energy

$5.60

-0.11 (-1.93%)

08:13
11/22/19
11/22
08:13
11/22/19
08:13
Initiation
Amplify Energy initiated  »

Amplify Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OLED

Universal Display

$197.75

-2.57 (-1.28%)

08:11
11/22/19
11/22
08:11
11/22/19
08:11
Downgrade
Universal Display rating change  »

Universal Display…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AB

AllianceBernstein

$29.23

-0.06 (-0.20%)

, CI

Cigna

$201.29

1.45 (0.73%)

08:11
11/22/19
11/22
08:11
11/22/19
08:11
Conference/Events
Gabelli to hold a conference »

Healthcare at a…

AB

AllianceBernstein

$29.23

-0.06 (-0.20%)

CI

Cigna

$201.29

1.45 (0.73%)

JNJ

Johnson & Johnson

$136.46

0.58 (0.43%)

PFE

Pfizer

$37.74

0.69 (1.86%)

WBA

Walgreens Boots Alliance

$60.59

-0.75 (-1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 07

    Dec

  • 09

    Dec

  • 11

    Dec

  • 21

    Jan

  • 06

    Feb

PEG

PSEG

$60.72

-0.47 (-0.77%)

08:10
11/22/19
11/22
08:10
11/22/19
08:10
Hot Stocks
PSEG announces Ralph LaRossa as COO, Sheila Rostiac as CDO »

PSEG announced several…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VG

Vonage

$7.46

0.25 (3.47%)

, SAP

SAP

$135.56

0.59 (0.44%)

08:10
11/22/19
11/22
08:10
11/22/19
08:10
Recommendations
Vonage, SAP analyst commentary  »

Investors should be…

VG

Vonage

$7.46

0.25 (3.47%)

SAP

SAP

$135.56

0.59 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.